期刊文献+

卡前列素氨丁三醇与米索前列醇在预防前置胎盘产后出血中的临床价值 被引量:24

Hemabate with misoprostol clinical value in preventing maternal placenta previa postpartum hemorrhage
下载PDF
导出
摘要 目的观察卡前列素氨丁三醇和米索前列醇在预防前置胎盘产后出血中的临床效果。方法选择在本院行剖宫产手术的前置胎盘孕妇70例,随机分为观察组和对照组,各35例。其中观察组35例采用子宫体注射卡前列素氨丁三醇250μg,对照组采用子宫体注射缩宫素20 U并米索前列醇400μg术后塞肛,两组同时均给予缩宫素20 U静脉点滴维持。比较两组产妇产后出血率、产后2小时及24小时平均出血量,同时观察有无胃肠道不良反应。结果对照组产妇产后出血率为74.3%(16例),产后2小时平均出血量为(433.57±83.7)ml,产后24小时平均出血量为(507.59±80.3)ml;观察组产妇产后出血率为14.3%(5例),产后2小时平均出血量为(271.23±50.4)ml,产后24小时平均出血量为(381.76±78.5)ml,观察组产妇产后2小时及24小时的出血量较对照组明显减少,经统计分析两组间数据比较差异具有显著性(P<0.05);两组间不良反应发生率差异无显著性(P>0.05)。结论卡前列素氨丁三醇预防前置胎盘产后出血疗效优于米索前列醇,建议临床推广应用。 Objective To observe the clinical effect of hemabate and misoprostol for preventing postpartum hemorrhage after cesarean section of pregnant women with placenta previa. Methods Selected 70 patients of cesarean section with placenta previa and andomly divided into two groups:treatment group and control group. Control group was injected oxytocin 20 U into their uterine corpus immediately after cesarean section and misoprostol 0.4 mg po, treatment group was injected hemabate 250 μg, then the two groups all were injected oxytocin 20 U by intravenous drip continuously. Then compared the bleeding rate,the bleeding amounts of 2 hours and 24 hours after operation. Results The control group’s bleeding rate was 74.3%, the bleeding amounts of 2 hours was (433.57±83.7) ml and 24 hours was (507.59±80.3) ml;The treatment group’s bleeding rate was 14.3%, the bleeding amounts of 2 hours was (271.23±50.4) ml and 24 hours was (381.76±78.5) ml. The data is statistically signiifcant. Conclusion Hemabate is more effective than misoprostol for preventing postpartum hemorrhage after cesarean section of women with placenta previa.
出处 《中国医学前沿杂志(电子版)》 2014年第4期45-48,共4页 Chinese Journal of the Frontiers of Medical Science(Electronic Version)
关键词 卡前列素氨丁三醇 米索前列醇 前置胎盘 产后出血 Hemabate Misoprostol Placenta previa Hemorrhage after cesarean section
  • 相关文献

参考文献9

二级参考文献58

  • 1赵莉,应豪.中央性前置胎盘剖宫产术大出血相关因素分析[J].上海医学,2005,28(9):734-736. 被引量:8
  • 2苏莉.欣母沛应用于前置胎盘剖宫产术中的疗效观察[J].中国医药,2007,2(9):568-569. 被引量:16
  • 3Arias,Fernando. Pharmacology of oxytoein and progtaglanding [ J]. Clin Obestet Oynecol,2000,43 ( 3 ) :455-468.
  • 4刘铭 段涛.产后出血的预防和处理指南.现代妇产科杂志,2007,:179-180.
  • 5Oya A,Nakai A,Miyake H,et al.Risk factors for peripartum blood transfusion in women with placenta previa:a retrospective analysis[J].J Nippon Med Sch,2008,75(3):146-151.
  • 6Hung TH,Hsien CC,Hsu JJ,et al.Risk factors for placenta previa in an Asian population[J].Int J Gynecol Obstet,2007,19:26.
  • 7Park CW,Moon KC,Park JS,et al.The frequency and clinical significance of intra-uterine infection and inflammation in patients with placenta previa and preterm labor and intact membranes[J].Placenta,2009,30(7):613-618.
  • 8Faiz AS,Ananth CV.Etiology and risk factors for placenta previa:an overview and meta-analysis of observational studies[J].J Matem Fetal Neonatal Med,2003,13:175.
  • 9Kampala,Uganda Paul Kiondo,Julius Wandabwa,et al.Risk factors for placenta praevia presenting with severe vaginal bleeding in Mulago hospital[J].Pat Doyle Afr Health Sci,2008,8(1):44-49.
  • 10Gielchinsky Y,Rojansky N,Fasouliotis SJ,et al.Placenta accreta-summary of 10 years:a survey of 310 cases[J].Obstet Gynecol,2004,104(3):527-530.

共引文献126

同被引文献142

引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部